Tech Center 1600 • Art Units: 1611 1614 1615 1628
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18612755 | MICROSPHERE-BASED DRUG DELIVERY PLATFORM FOR DELIVERY OF IMMUNOTHERAPEUTIC AGENTS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18239036 | PATCH GRAFT COMPOSITIONS FOR CELL ENGRAFTMENT | Final Rejection | The University of North Carolina at Chapel Hill |
| 19093009 | PARTICLE-FORM HYBRID-SCALE FIBER MATRIX | Non-Final OA | Solventum Intellectual Properties Company |
| 18695440 | COMPOSITIONS FOR USE | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18713334 | SOLID POWDER COSMETIC PRODUCT | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18608586 | ORALLY DISINTEGRATING NICOTINE TABLET FOR USE UNDER LIP | Final Rejection | Fertin Pharma A/S |
| 18695554 | SOLID COMPOSITION FOR DYEING KERATIN | Non-Final OA | KAO CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy